STOCK TITAN

West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has introduced Daikyo Crystal Zenith® (CZ) Nested Vials at the International Society for Cell and Gene Therapy Annual Meeting in Vancouver, Canada from May 29-June 1, 2024.

Designed to meet ISO 8362-1 standards, the vials are compatible with a range of aseptic fill-finish equipment. They offer features such as break resistance, low particulate specification, and low risk of chemical interaction.

Available in 2mL and 10mL sizes, the vials come with flexible closure options and are suitable for storing gene therapy drugs from preclinical to commercial phases. Chief Commercial Officer Cindy Reiss-Clark stated that this product expands CZ's platform for flexible filling solutions of sensitive molecules.

Positive
  • Introduction of CZ Nested Vials expands West's product line.
  • Vials designed to meet ISO 8362-1 standards, broadening compatibility.
  • Features like break resistance and low particulate specification enhance product quality.
  • Suitable for a wide range of therapies including cell and gene therapies and radiopharmaceuticals.
  • Flexible closure solutions for different capping requirements.
  • Effective from preclinical to commercial phases, increasing market application.
Negative
  • No specific financial data provided to indicate immediate impact on revenues.
  • Potential challenges in gaining market acceptance for new product.
  • information on cost-effectiveness compared to existing solutions.

CZ's Nested Vials are designed to meet the exterior dimensions of glass standard ISO 8362-1 and offer broad compatibility with various aseptic fill-finish equipment available in the market.

EXTON, Pa., May 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it will unveil its new Daikyo Crystal Zenith® (CZ) Nested Vials in Tub at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting taking place in Vancouver, Canada from May 29- June 1.

Designed to meet the exterior dimensions of glass standard ISO-8362-1, CZ nested vials are a demonstrated containment solution for cell and gene therapies, radiopharmaceuticals, and sensitive molecules. CZ's attributes, such as maintaining container closure integrity down to cryogenic temperatures, superior functional recovery of viral vectors, low particulate specification (2% USP <788>), break resistance, and low risk of chemical interaction, make it ideal for advanced therapies. CZ vials have demonstrated to be effective in safely storing gene therapy drugs and meeting the packaging demands from preclinical to commercial phases.

"West has been at the forefront of pharmaceutical packaging for over 100 years and is the market leader for containment solutions for cell and gene therapy treatments," said Cindy Reiss-Clark, Chief Commercial Officer at West. "This new offering expands the CZ platform to provide packaging configuration options for flexible filling solutions of sensitive molecules."

Product Specifications 

  • CZ nested vials are available in 2mL and 10mL, and with ISO 8362-1 exterior dimensions.
  • These vials offer flexible closure solutions with crimped closures using NovaPure® stoppers or PLASCAP® press-fit closures with Daikyo stoppers to meet manual, semi-automated or automated capping requirements.
  • The ready-to-use nested vials are first layered with a Tyvek® slip sheet, heat sealed with a breathable Tyvek® lid, double bagged and sterilized.
  • The rigid structure and overall design of the vial nest tub protects the vials during transit and promotes machinability.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.    

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com

West and the diamond logo and NovaPure are registered trademarks of West Pharmaceutical Services, Inc.

Crystal Zenith and PLASCAP are registered trademarks of Daikyo Seiko, Ltd.

Tyvek® is a registered trademark of DuPont de Nemours, Inc. or its affiliate.

Crystal Zenith technology is licensed from Daikyo Seiko, Ltd.

© 2024 West Pharmaceutical Services, Inc.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-introduces-daikyo-crystal-zenith-cz-ready-to-use-nested-vials-in-tub-at-the-international-society-for-cell-and-gene-therapy-302157350.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

What are West Pharmaceutical Services' new product features presented at ISCT 2024?

West introduced Daikyo Crystal Zenith® (CZ) Nested Vials, which meet ISO 8362-1 standards and are compatible with various aseptic fill-finish equipment.

When and where did West present the new CZ Nested Vials?

West presented the CZ Nested Vials at the ISCT Annual Meeting in Vancouver, Canada from May 29 to June 1, 2024.

What are the sizes available for CZ Nested Vials?

The CZ Nested Vials are available in 2mL and 10mL sizes.

What are the special features of CZ Nested Vials?

CZ Nested Vials offer break resistance, low particulate specification, and low risk of chemical interaction, making them suitable for advanced therapies.

Why are CZ Nested Vials significant for cell and gene therapies?

CZ Nested Vials are significant because they ensure container closure integrity down to cryogenic temperatures and provide superior functional recovery of viral vectors.

What are the closure options available for CZ Nested Vials?

CZ Nested Vials offer flexible closure solutions with crimped closures using NovaPure® stoppers or PLASCAP® press-fit closures with Daikyo stoppers.

West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

WST Latest News

WST Stock Data

23.81B
72.54M
0.58%
95.81%
2.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
EXTON